Carboxypeptidase A2
Carboxypeptidase A2 (CPA2) is an enzyme that in humans is encoded by the CPA2 gene. This enzyme is part of the metallocarboxypeptidase family, which is involved in the catabolism and modification of proteins. Carboxypeptidases remove amino acids from the carboxyl end of proteins or peptides. CPA2 is specifically involved in the digestion of food proteins in the digestive system, making it crucial for the proper absorption of dietary proteins.
Function[edit]
Carboxypeptidase A2 is a pancreatic enzyme that plays a significant role in the digestive system. It works by cleaving the C-terminal amino acid from peptide chains, a process essential for the complete digestion of food proteins into absorbable units. This enzyme is particularly important in the breakdown of complex dietary proteins into simpler amino acids, which can then be absorbed by the intestines and utilized by the body for various physiological functions, including tissue repair and growth.
Structure[edit]
The structure of CPA2 is characterized by a zinc ion that is essential for its enzymatic activity. This zinc ion is located at the active site of the enzyme and plays a critical role in the catalysis of peptide bond hydrolysis. The enzyme's structure is designed to bind specifically to the C-terminal end of peptide chains, allowing for precise and efficient cleavage of amino acids.
Genetics[edit]
The CPA2 gene is located on chromosome 7 in humans. Mutations in this gene are rare but can affect the enzyme's function, potentially leading to digestive problems due to the inefficient breakdown of dietary proteins. The genetic regulation of CPA2 expression is complex and involves various factors, including hormonal signals that correspond to the digestive process.
Clinical Significance[edit]
While mutations in the CPA2 gene are uncommon, the role of CPA2 in the digestive system makes it a potential target for therapeutic intervention in conditions related to protein malabsorption or digestive inefficiencies. Inhibitors of CPA2 could also be of interest in the context of certain diseases where the modulation of protein breakdown could have therapeutic benefits.
See Also[edit]
References[edit]
<references/>
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian